Yvonne M. Mowery, MD, PhD

UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania, United States

Disclosure information not submitted.

Presentation(s):

• Paper 81 - PEMBROLIZUMAB, RADIOTHERAPY, & SURGERY VS RADIOTHERAPY & SURGERY FOR STAGE III SOFT TISSUE SARCOMA OF THE EXTREMITY: OUTCOMES & SARCOMA IMMUNE CLASS ANALYSIS IN SU2C-SARC032 RANDOMIZED CLINICAL TRIAL

  Saturday, November 16, 2024
  10:30 AM – 12:00 PM PST

• Paper 96 - PERSONALIZED CTDNA ANALYSIS IS ASSOCIATED WITH OUTCOMES AFTER PREOPERATIVE RADIOTHERAPY WITH OR WITHOUT PEMBROLIZUMAB FOR STAGE 3 SOFT TISSUE SARCOMAS ON SU2C-SARC032

  Saturday, November 16, 2024
  2:00 PM – 3:00 PM PST